文献速递头颈外科

FDG-PET代谢肿瘤参数用于复发头颈癌再程放疗的预后价值

FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
PubMed 文献 · Laryngoscope · 2018-03-24

本研究纳入29例患者共34个复发头颈癌病灶,评估再程放疗前FDG-PET测得的SUV与MTV对生存终点的预测价值。单因素分析显示MTV(连续变量及以266 cc为界值)均预测总生存下降(P<0.05),多因素分析证实MTV为死亡的独立预测因子。PET衍生的MTV可能有助于风险分层和指导再程放疗试验。

要点

  • 再程放疗前FDG-PET的MTV可预测复发头颈癌患者总生存下降。
  • MTV是死亡的独立预测因子,或可用于风险分层。
  • SUV与生存终点的相关性在本研究中未明确报告。

核心结论

  • PET衍生的MTV可能作为复发头颈癌再程放疗中有价值的风险分层因素,并指导未来再程放疗试验的治疗决策。

研究设计与样本

  • 回顾性评估29例患者共34个可评估的复发头颈癌病灶,均接受再程放疗。
  • 探索FDG-PET最大标准化摄取值(SUV)和代谢肿瘤体积(MTV)与生存终点的相关性,多因素分析采用Cox比例风险模型。
  • 证据等级为4级。

主要发现

  • MTV中位值为366 cc(范围0-3,567 cc),SUV中位值为8.1(范围0-25),大体肿瘤体积中位值为48.5 cc(范围1-190 cc),后者以50% SUVmax阈值勾画。
  • 单因素分析中,MTV作为连续变量及以中位值266 cc为界值均预测总生存下降(两者P<0.05)。
  • MTV作为连续变量时,无进展生存(P=0.05)、野内控制(P=0.06)和局部区域控制(P=0.07)呈下降的强趋势。
  • 多因素分析证实MTV是死亡的独立预测因子。

临床怎么用

  • 对复发头颈癌拟行再程放疗的患者,可考虑参考FDG-PET测得的MTV进行风险分层。
  • MTV较高的患者总生存较差,或需在再程放疗决策中综合评估。

局限性

  • 样本量小(29例患者、34个病灶),证据等级为4级。
  • 为回顾性分析,MTV与无进展生存、野内控制、局部区域控制的关联仅呈趋势(P值0.05-0.07),未达统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The utility of fluorodeoxyglucose positron emission tomography (FDG-PET) imaging to predict outcome has been well-established for patients undergoing definitive radiation in the initial management of head and neck cancer. However, the usefulness of this modality in the recurrent setting remains uncertain. We sought to evaluate the prognostic value of metabolic tumor parameters measured on FDG-PET in patients treated by reirradiation for recurrent head and neck cancer. METHODS: Thirty-four tumors occurring in 29 patients were reirradiated and were evaluable. The most common disease sites were the oropharynx (n = 9), oral cavity (N = 8), and nasopharynx (n = 6). Potential correlations of FDG-PET maximum standardized uptake value (SUV) and metabolic tumor volume (MTV) with survival endpoints were explored. Multivariate analysis was performed using Cox proportional hazard. RESULTS: The median MTV, SUV, and gross tumor volume, as delineated using the 50% SUVmax threshold, were 366 cc (range, 0-3,567 cc), 8.1 (range, 0-25), and 48.5 cc (range, 1-190 cc), respectively. On univariate analysis, both MTVs (as measured as a continuous variable and using the median value of 266 cc as cutoff) were predictive of decreased overall survival (P < 0.05 for both). A strong trend toward decreased progression-free survival (P = 0.05), in-field control (P = 0.06), and locoregional control (P = 0.07) was also observed with increasing MTV when analyzed as a continuous variable. Multi-variate analysis confirmed MTV as an independent predictor of mortality. CONCLUSION: The PET-derived parameter MTV may serve as a potentially valuable factor for risk stratification and for guiding treatment in future reirradiation trials. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:2345-2350, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Velez MA, Veruttipong D, Wang PC, et al. FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer. Laryngoscope. 2018. PMID: 29573279. doi:10.1002/lary.27173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。